Austedo XR 42 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1Z7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,051
Award facts
- Contract value 100% obligated
- $22,050.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,050.86 delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of AUSTEDO XR 42 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of January 12, 2026 and performance location in Conshohocken, Pennsylvania. The award represents a task order executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
This delivery order exemplifies the ongoing pharmaceutical supply relationship between the Defense Logistics Agency and Amerisourcebergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. AUSTEDO XR is a neurological treatment medication, consistent with the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. The non-competed award structure reflects Amerisourcebergen's established capability to fulfill federal medical supply requirements through its established prime vendor agreement with DLA Troop Support, enabling efficient procurement of critical medications needed by military treatment facilities and other government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FA1Z7?
SPE2DR26FA1Z7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FA1Z7 worth?
The government has obligated $22,051 on SPE2DR26FA1Z7.
Is contract SPE2DR26FA1Z7 an order under another contract?
Yes. SPE2DR26FA1Z7 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1Z7 competed?
The extent of competition for SPE2DR26FA1Z7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award